Rankings
▼
Calendar
NVAX FY 2021 Earnings — Novavax, Inc. Revenue & Financial Results | Market Cap Arena
NVAX
Novavax, Inc.
$2B
FY 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$198M
+782.5% YoY
Gross Profit
$198M
100.0% margin
Operating Income
-$1.7B
-853.6% margin
Net Income
-$1.7B
-882.5% margin
EPS (Diluted)
$-23.44
Cash Flow
Operating Cash Flow
$323M
Free Cash Flow
$265M
Stock-Based Comp.
$184M
Balance Sheet
Total Assets
$2.6B
Total Liabilities
$2.9B
Stockholders' Equity
-$352M
Cash & Equivalents
$1.5B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$198M
$22M
+782.5%
Gross Profit
$198M
$22M
+782.5%
Operating Income
-$1.7B
-$417M
-304.7%
Net Income
-$1.7B
-$418M
-316.9%
← Q4 2020
All Quarters
Q1 2021 →